Zhejiang Xingyue Pharmaceutical Technology

Zhejiang Xingyue Pharmaceutical Technology is a Chinese pharmaceutical company primarily engaged in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and chemical intermediates. A subsidiary of the Xingyue Group, the company focuses on high-demand therapeutic areas including cardiovascular, respiratory, and anti-infective treatments. Its product portfolio features key APIs such as Rosuvastatin Calcium, Atorvastatin Calcium, and Montelukast Sodium. The company operates GMP-certified manufacturing facilities and serves a global clientele, positioning itself as a reliable supplier in the pharmaceutical supply chain. It was listed on China's National Equities Exchange and Quotations (NEEQ) in 2016 and is recognized as a high-tech enterprise in Zhejiang Province.